10 Best International Stocks To Buy Right Now: AVEO Pharmaceuticals Inc.(AVEO)
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of cancer therapeutics. The company?s lead product candidate, Tivozanib (AV-951), is a novel, highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2, and 3. It is also leading the clinical development of AV-299, which includes conducting multiple Phase I clinical trials and preparing for the conduct of multiple Phase II clinical trials. The company?s product candidate in preclinical development is AV-203, a potent ErbB3 antibody that has demonstrated efficacy in vivo. It has strategic partnerships with OSI Pharmaceuticals, Inc., Merck, and Biogen Idec, Inc. AVEO Pharmaceuticals was formerly known as GenPath Pharmaceuticals, Inc. and changed its name to AVEO Pharmaceuticals, Inc. in March 2005. The company was founded in 2001 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By Sean Williams]
What: Shares of AVEO Pharmaceuticals (NASDAQ: AVEO ) , a cancer therapeutics company, collapsed as much as 27% following the release of briefing documents today in anticipation of AVEO's meeting with the Food and Drug Administration panel on Thursday.
- [By Brian Orelli]
AVEO Pharmaceuticals' (NASDAQ: AVEO ) announced yesterday that the Food and Drug Administration rejected its kidney cancer drug tivozanib.
- [By Sean Williams]
Will AVEO be on target?
The other FDA decision that should have the attention of biotech investors this week is AVEO Pharmaceuticals' (NASDAQ: AVEO ) Tivozanib, which is set to go before the FDA's review panel on Thursday.
source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/10-best-international-stocks-to-buy-right-now.html
No comments:
Post a Comment